Leonteq Securities AG’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Leonteq Securities AG's HALO Position: Q2 2026 in Review
Leonteq Securities AG increased its Halozyme (HALO) stake by 80% in Q2 2026, buying an estimated $19.1K and bringing the position to 630 shares worth $49.3K. The position accounts for ﹤0.01% of the portfolio, ranked #810.
Leonteq Securities AG first reported a position in HALO in Q3 2021 and has held it in 15 quarters since. The position peaked at $60.9K in Q2 2022. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Leonteq Securities AG held 630 shares of Halozyme worth $49.3K as of Q2 2026.
- Leonteq Securities AG bought 280 Halozyme shares in Q2 2026, an estimated $19.1K.
- Halozyme made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #810 holding.
- Leonteq Securities AG first reported a position in Halozyme in Q3 2021 and has held it in 15 quarters since.
- Leonteq Securities AG's Halozyme position peaked at $60.9K in Q2 2022.
- 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.